Medvance Linkedin
Medvance Linkedin

Webinar : What does the Brexit effect mean for UK patient access?

Mar 9, 2022

Ursula von der Leyen


Remap Consulting, joined by Paul Miller of NICE, will be reviewing the regulatory and market access impacts of Brexit on a manufacturer’s European launch sequence and will summarise the recent changes at NICE.

The panel will aim to answer these two questions:

  • Will it be worth the trouble launching in the UK in five years’ time?
  • Should the UK be deprioritised in the launch sequence


Where : Online – Zoom

Date : March 29, 2022 – 9pm (UTC+1)